Case report
Open access
Sep 2026
Successful induction of remission with azacitidine, venetoclax, and dasatinib followed by allogeneic hematopoietic stem cell transplantation in a patient with Philadelphia chromosome-positive mixed phenotype acute leukemia (B/myeloid): a case report
An induction regimen based on azacitidine, venetoclax, and dasatinib may represent a safe and effective therapeutic strategy for adult patients with Ph+, bilineal MPAL, particularly when augmented with agents targeting distinct lineage components.
Juan Zhang, Yan Huang, Liang-Kui Luo et al.
· Frontiers in Medicine · 0 citations